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Abstract. Clinical pathways are often promoted as the holy grail of efficient 
healthcare provision. However, our experiences during the Swiss research project 
Hospital of the Future demonstrated that most Swiss hospitals do not implement 
clinical pathways in the sense of ‘… a document describing the common process of 
a multidisciplinary treatment for a particular type of patient’. In this paper, we will 
discuss reasons for the lack of pathway implementations. We differentiate between 
three different categories of explanations: (i) organization-specific impediments, (ii) 
environmental hurdles, and (iii) inherent problems of clinical pathways. Without 
additional support and regulation by the policy maker, it seems rather unlikely that 
an increase of pathway implementations will take place in the near-future in 
Switzerland.  
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1. Introduction 
Streamlining healthcare processes by establishing standards and transparency 
mechanisms for multidisciplinary treatments has beneficial consequences for the quality 
and cost-effectiveness of healthcare [1–3]. Clinical pathways provide a systematic way 
of standardizing processes using workflow documents to support the treatment process 
for a particular type of patient [4]. They should be distinguished from clinical guidelines, 
which represent state-of-art diagnosis and treatment recommendations without 
describing the concrete implementation of the process flow within a healthcare 
institution.  
Process-orientation is nothing new and has been promoted by public institutions 
such as the Agency for Healthcare Research and Quality (AHRQ). For quality 
improvement, processes have to be monitored and consciously adapted and AHRQ 
provides standards for monitoring, documenting and supporting healthcare processes. 
An example is the process analysis tool for fall prevention that helps finding gaps and 
problems in the current workflows and helps to change these processes [5]. 
On the other hand, Swiss hospitals which were leading in the development of clinical 
pathways [6] have discontinued their development and further use (personal 
communication with responsible staff). Six Swiss hospitals in our research project [7] 
had limited use. In this context, we examined the question why clinical pathways are not 
implemented as often as the literature might suggest.  
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The context of our work was the Swiss research project “Hospital of the Future” [7], 
which aimed at realizing prototypical IT applications for a digitally enhanced future of 
the Swiss healthcare system. Clinical pathways were an important issue throughout the 
project, therefore we arranged stakeholder workshops with all project partners to obtain 
an inventory of existing methods and tools. We used the world-café format to discuss 
pathway related questions with groups of project partners and a “table host” using flip 
chart annotations [8]. The questions discussed in the world café are:  
a) Do we already have efficient hospital processes even without clinical pathways? 
b) How can we assess the costs for developing and implementing pathways? 
c) What are the main hurdles for implementing clinical pathways?  
 
In addition, we conducted a systematic PubMed search with the following keywords:  
- "clinical pathways"[All Fields] AND "disadvantages"[All Fields] 
- "clinical pathways"[All Fields] AND "negative"[All Fields] 
- "clinical pathways"[All Fields] AND "barriers"[All Fields] 
We were interested in current publications of 2018. The abstracts were screened, 
and relevant articles included in the study. We analyzed the information in these articles 
in combination with the world café results.  
3. Results 
The literature research delivered 0 + 6 + 8 = 14 matches. Four papers were classified as 
highly relevant [9,10,11,12]. Classification of obstacles for clinical pathway use resulted 
in three categories: (i) organization-specific impediments, (ii) environmental hurdles, 
and (iii) inherent problems of clinical pathways (see Figure 1). 
3.1. Organization-specific impediments  
In [9], a hospital funding reform based on clinical pathways in Ontario, Canada is 
described, and one main conclusion is that “hospitals sometimes found it easier to focus 
on containing and standardizing costs of care than on implementing standardized care 
processes that adhere to best clinical practices.” Three factors relevant for clinical 
pathways were identified: complexity of required changes, internal capacity for 
organizational changes, and availability of external support to manage change.  Without 
such supports “hospitals may enact quick fixes aimed mainly at preserving budgets, 
rather than to pursue evidence- and value-based changes in care management.” 
The workshop results corroborate these findings and add some further insights. 
Besides missing internal capacity and external support, it is also the lack of will to 
participate in the process change that constitutes an organizational impediment for the 
use of clinical pathways. At first, standardizing processes within a clinical pathway 
creates full transparency, which is frequently not desired. Knowledge and experiences 
represent some sort of autonomy and health care professionals may not want to disclose 
their implicit knowledge in order to avoid the feeling of getting more and more 
interchangeable and to lose their autonomy. Second, almost all hospitals are already 
process-oriented due to established quality management systems. Additional patient 
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related restrictions of the working processes have the potential to deteriorate efficiency 
instead of improving it.  
In summary, defining, developing, and implementing clinical pathways is often 
regarded as too expensive or not feasible, even though the potential advantages are 
acknowledged. Schechtman et al. [10] investigated emergency department (ED) leader 
attitudes towards clinical pathways which guide admission decisions. They contacted 
135 EDs and received 64 (48%) responses. Only eight sites confirmed that they had 
implemented clinical care pathways to reduce avoidable admissions.  
3.2. Environmental hurdles  
Jabbour et al. [11] conducted a qualitative study among 15 community hospitals in 
Ontario and describe a set of barriers and enablers in the context of clinical pathways for 
pediatric asthma respectively pediatric vomiting and diarrhea. As environmental factors 
they identified the attitude of other stakeholders towards pathways, the availability of 
user-friendly pathway guiding and documentation tools, and funding and public pressure, 
be it by regulations or through prestige issues. The group used the COM-B model 
(capability, opportunity, and motivation of the behavior change wheel) for the mapping 
and Interaction investigation of barriers and enablers. The environmental factors are 
mainly related to the opportunity part and have thus impact on increase or decrease of 
capabilities and motivations.  
Within the world café, we derived another categorization: local versus trans-sectoral 
pathways, pressure of health insurance companies to reduce costs, and the integration of 
pathways within cross-institutional structures like the coming Swiss electronic health 
record (EHR). The main difference to the COM-B model is the focus on disabling instead 
of enabling factors. We tried to identify those environmental factors that pose important 
hurdles. One such factor is the missing network effect when no other external pathway 
implementations create pressure for internal adoption. As the digital change within the 
Swiss healthcare system is imminent, it seems important for new pathway 
implementations that they are part of this change; otherwise, most hospitals have 
duplicate work which they are not willing or able to handle.     
Summarizing, the input from the Swiss healthcare environment lacks strong support 
for clinical pathways which decreases the motivation for implementation; especially, 
when other changes/structures are imposed by the policy maker. Pathways should be part 
of the cross-institutional infrastructure in order to support efficient trans-sectoral 
healthcare and to avoid additional workload. Without additional support and regulation 
by the policy maker an increase of pathway implementations in Switzerland seems 
unlikely in the near future.    
3.3. Inherent problems of clinical pathways  
Today we assume with some evidence that clinical pathways can and will increase 
efficiency, quality and cost effectiveness. But more research and better methodology is 
needed for the assessment of clinical pathway effects. Shanbhag et al. [12] investigated 
the acceptance of guideline recommendations in heart failure in a systematic review of 
38 studies. Although improvements of process quality could be demonstrated in these 
studies, they were rarely accompanied by improvements in clinical outcome. Especially 
complex treatments are difficult to standardize with clinical pathways. 
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Our own workshop confirmed the lack of substantial outcome improvement and 
provided some additional insight into problems. Frequently, the following central criteria 
are used when deciding for and against the implementation of clinical pathways for 
certain types of patients [4]: (i) number of patient expected to be on the pathway; (ii) 
related average cost; (iii) complexity of the treatment; (iv) availability of quality 
indicators; (v) definite start and end of the path. Apart from the first two, these criteria 
are difficult to assess. Furthermore, a division between pathway patients and those 
without results in restricted treatment freedom in one and full treatment flexibility in the 
other case; a situation with potential for conflict.  
Standardization of processes aims at improving the average, whereas physicians 
have to account for the idiosyncrasies of patients. Flexibility for multimorbid patients 
and variability in time and process steps are central for medicine as an art. To a certain 
degree, pathways can consider that, but the trade-off between flexibility and 
standardization should be openly discussed. Implementation of clinical pathways 
requires massive change management in order to obtain benefits.  
  
Figure 1. Hurdles and enhancers of clinical pathway implementation. 
4. Discussion 
Our starting point was the scarce use and sometimes even disregard of clinical pathways 
in Swiss hospitals. Therefore, we focused on the disadvantages of clinical pathways. We 
classified the hurdles for implementation into (i) organization-specific impediments, (ii) 
environmental hurdles, and (iii) inherent problems of clinical pathways.  
We fully acknowledge the potential benefits of clinical pathways reported e.g. in 
[13]:   
- Reduced waiting time within and between divisions, 
- Reduction of the treatment costs by avoiding duplication of work, waiting times 
and inefficient use of resources, 
- Reduced risk of treatment errors, 
- Increased knowledge transfer. 
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Non-adoption of clinical pathways in practice is not just a matter of inherent 
disadvantages outweighing the benefits, but rather lacking external and organizational 
support. If, for example, clinical pathways cannot be easily represented in the hospital 
documentation systems, and if several different applications are necessary for path 
support, successful implementation of pathways will fail. A systematic way of process-
orientation, which is supported by organizational and technological means, can exploit 
all of the advantages promised by pathways.  
In addition to the disadvantages listed, there are also two further related negative 
aspects associated with pathways. On the hand, dehumanization of work is a possibility 
due to reduced room for creativity. A strict time schedule and a list of activities to be 
done in certain stages can have undesired impacts on job satisfaction. On the other hand, 
the relationship between health professionals and the patient can get less personal. 
Patients do not want to be treated as things or process elements, but as persons with 
dignity. Both aspects, job and patient satisfaction, go hand in hand, which means that 
pathways should consider room for personal exchange beyond functional requirements, 
leading to patient- and employee- centered clinical pathways [14].  
In summary, there are indeed many reasons for not implementing clinical pathways, 
but none of them are insurmountable. Inherent problems of clinical pathways can be 
reduced by allowing more flexibility than in industrial settings, by a transparent 
discussion culture and by considering change management right from the start. 
Organization-specific impediments can be tackled, for example, by external counselling, 
integration of pathways into the quality management systems and by fostering 
interdisciplinary exchange regarding process design. Finally, environmental hurdles 
should be addressed by regulators with an integrative view on clinical pathways in the 
wider context of the digitalization in the healthcare sector.  
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